カテゴリー： LP Information, 世界, 部品/材料

世界のリメゲパントAPI市場予測 2023年-2029年

◆英語タイトル：Global Rimegepant API Market Growth 2023-2029
	◆商品コード：LP23JU3224 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：103 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のリメゲパントAPI市場」は、過去の販売実績から2022年の世界のリメゲパントAPIの総販売量を検討し、2023年から2029年の予測されるリメゲパントAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のリメゲパントAPIの市場規模を掲載し、XXX百万米ドル規模の世界のリメゲパントAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のリメゲパントAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のリメゲパントAPI市場における各社の独自のポジションをより深く理解するために、リメゲパントAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のリメゲパントAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。リメゲパントAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。リメゲパントAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。リメゲパントAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

リメゲパントAPIの世界主要メーカーとしては、Cayman Chemical、 MedKoo Biosciences、 Taiclone、 Clearsynth、 TargetMol Chemicals、 AbMole BioScience、 Toronto Research Chemicals、 Metrochem、 Aurobindo、 Hetero Drugs、 Moehs Iberica、 Changzhou Pharmaceutical Factoryなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のリメゲパントAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではリメゲパントAPI市場をセグメンテーションし、種類別 (純度≧98%、純度≧99%)、用途別 (研究機関、製薬、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度≧98%、純度≧99%

・用途別区分：研究機関、製薬、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のリメゲパントAPI市場の10年間の市場状況・展望は？
・世界および地域別に見たリメゲパントAPI市場成長の要因は何か？
・リメゲパントAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・リメゲパントAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：リメゲパントAPIの年間販売量2018-2029、地域別現状・将来分析
・リメゲパントAPIの種類別セグメント：純度≧98%、純度≧99%
・リメゲパントAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・リメゲパントAPIの用途別セグメント：研究機関、製薬、その他
・リメゲパントAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のリメゲパントAPI市場
・企業別のグローバルリメゲパントAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別のリメゲパントAPIの年間売上：2018-2023年の売上、市場シェア
・企業別のリメゲパントAPI販売価格
・主要企業のリメゲパントAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

リメゲパントAPIの地域別レビュー
・地域別のリメゲパントAPI市場規模2018-2023：年間販売量、売上
・主要国別のリメゲパントAPI市場規模2018-2023：年間販売量、売上
・南北アメリカのリメゲパントAPI販売の成長
・アジア太平洋のリメゲパントAPI販売の成長
・ヨーロッパのリメゲパントAPI販売の成長
・中東・アフリカのリメゲパントAPI販売の成長

南北アメリカ市場
・南北アメリカの国別のリメゲパントAPI販売量、売上（2018-2023）
・南北アメリカのリメゲパントAPIの種類別販売量
・南北アメリカのリメゲパントAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のリメゲパントAPI販売量、売上（2018-2023）
・アジア太平洋のリメゲパントAPIの種類別販売量
・アジア太平洋のリメゲパントAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のリメゲパントAPI販売量、売上（2018-2023）
・ヨーロッパのリメゲパントAPIの種類別販売量
・ヨーロッパのリメゲパントAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のリメゲパントAPI販売量、売上（2018-2023）
・中東・アフリカのリメゲパントAPIの種類別販売量
・中東・アフリカのリメゲパントAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・リメゲパントAPIの製造コスト構造分析
・リメゲパントAPIの製造プロセス分析
・リメゲパントAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・リメゲパントAPIの主要なグローバル販売業者
・リメゲパントAPIの主要なグローバル顧客

地域別のリメゲパントAPI市場予測レビュー
・地域別のリメゲパントAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・リメゲパントAPIの種類別市場規模予測
・リメゲパントAPIの用途別市場規模予測

主要企業分析
Cayman Chemical、 MedKoo Biosciences、 Taiclone、 Clearsynth、 TargetMol Chemicals、 AbMole BioScience、 Toronto Research Chemicals、 Metrochem、 Aurobindo、 Hetero Drugs、 Moehs Iberica、 Changzhou Pharmaceutical Factory
・企業情報
・リメゲパントAPI製品
・リメゲパントAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Rimegepant is a small molecule inhibitor of the calcitonin gene-related peptide (CGRP) receptor that blocks the action of CGRP, a potent vasodilator believed to play a role in migraine headaches
LPI (LP Information)’ newest research report, the “Rimegepant API Industry Forecast” looks at past sales and reviews total world Rimegepant API sales in 2022, providing a comprehensive analysis by region and market sector of projected Rimegepant API sales for 2023 through 2029. With Rimegepant API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rimegepant API industry.
This Insight Report provides a comprehensive analysis of the global Rimegepant API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rimegepant API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rimegepant API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rimegepant API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rimegepant API.
The global Rimegepant API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rimegepant API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rimegepant API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rimegepant API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rimegepant API players cover Cayman Chemical, MedKoo Biosciences, Taiclone, Clearsynth, TargetMol Chemicals, AbMole BioScience, Toronto Research Chemicals, Metrochem and Aurobindo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rimegepant API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Research Institute
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Cayman Chemical
MedKoo Biosciences
Taiclone
Clearsynth
TargetMol Chemicals
AbMole BioScience
Toronto Research Chemicals
Metrochem
Aurobindo
Hetero Drugs
Moehs Iberica
Changzhou Pharmaceutical Factory
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rimegepant API market?
What factors are driving Rimegepant API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rimegepant API market opportunities vary by end market size?
How does Rimegepant API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rimegepant API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rimegepant API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rimegepant API by Country/Region, 2018, 2022 & 2029
2.2 Rimegepant API Segment by Type
2.2.1 Purity ≥ 98 %
2.2.2 Purity ≥ 99 %
2.3 Rimegepant API Sales by Type
2.3.1 Global Rimegepant API Sales Market Share by Type (2018-2023)
2.3.2 Global Rimegepant API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rimegepant API Sale Price by Type (2018-2023)
2.4 Rimegepant API Segment by Application
2.4.1 Research Institute
2.4.2 Pharmaceutical
2.4.3 Others
2.5 Rimegepant API Sales by Application
2.5.1 Global Rimegepant API Sale Market Share by Application (2018-2023)
2.5.2 Global Rimegepant API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rimegepant API Sale Price by Application (2018-2023)
3 Global Rimegepant API by Company
3.1 Global Rimegepant API Breakdown Data by Company
3.1.1 Global Rimegepant API Annual Sales by Company (2018-2023)
3.1.2 Global Rimegepant API Sales Market Share by Company (2018-2023)
3.2 Global Rimegepant API Annual Revenue by Company (2018-2023)
3.2.1 Global Rimegepant API Revenue by Company (2018-2023)
3.2.2 Global Rimegepant API Revenue Market Share by Company (2018-2023)
3.3 Global Rimegepant API Sale Price by Company
3.4 Key Manufacturers Rimegepant API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rimegepant API Product Location Distribution
3.4.2 Players Rimegepant API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rimegepant API by Geographic Region
4.1 World Historic Rimegepant API Market Size by Geographic Region (2018-2023)
4.1.1 Global Rimegepant API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rimegepant API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rimegepant API Market Size by Country/Region (2018-2023)
4.2.1 Global Rimegepant API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rimegepant API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rimegepant API Sales Growth
4.4 APAC Rimegepant API Sales Growth
4.5 Europe Rimegepant API Sales Growth
4.6 Middle East & Africa Rimegepant API Sales Growth
5 Americas
5.1 Americas Rimegepant API Sales by Country
5.1.1 Americas Rimegepant API Sales by Country (2018-2023)
5.1.2 Americas Rimegepant API Revenue by Country (2018-2023)
5.2 Americas Rimegepant API Sales by Type
5.3 Americas Rimegepant API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rimegepant API Sales by Region
6.1.1 APAC Rimegepant API Sales by Region (2018-2023)
6.1.2 APAC Rimegepant API Revenue by Region (2018-2023)
6.2 APAC Rimegepant API Sales by Type
6.3 APAC Rimegepant API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rimegepant API by Country
7.1.1 Europe Rimegepant API Sales by Country (2018-2023)
7.1.2 Europe Rimegepant API Revenue by Country (2018-2023)
7.2 Europe Rimegepant API Sales by Type
7.3 Europe Rimegepant API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rimegepant API by Country
8.1.1 Middle East & Africa Rimegepant API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rimegepant API Revenue by Country (2018-2023)
8.2 Middle East & Africa Rimegepant API Sales by Type
8.3 Middle East & Africa Rimegepant API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rimegepant API
10.3 Manufacturing Process Analysis of Rimegepant API
10.4 Industry Chain Structure of Rimegepant API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rimegepant API Distributors
11.3 Rimegepant API Customer
12 World Forecast Review for Rimegepant API by Geographic Region
12.1 Global Rimegepant API Market Size Forecast by Region
12.1.1 Global Rimegepant API Forecast by Region (2024-2029)
12.1.2 Global Rimegepant API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rimegepant API Forecast by Type
12.7 Global Rimegepant API Forecast by Application
13 Key Players Analysis
13.1 Cayman Chemical
13.1.1 Cayman Chemical Company Information
13.1.2 Cayman Chemical Rimegepant API Product Portfolios and Specifications
13.1.3 Cayman Chemical Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cayman Chemical Main Business Overview
13.1.5 Cayman Chemical Latest Developments
13.2 MedKoo Biosciences
13.2.1 MedKoo Biosciences Company Information
13.2.2 MedKoo Biosciences Rimegepant API Product Portfolios and Specifications
13.2.3 MedKoo Biosciences Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 MedKoo Biosciences Main Business Overview
13.2.5 MedKoo Biosciences Latest Developments
13.3 Taiclone
13.3.1 Taiclone Company Information
13.3.2 Taiclone Rimegepant API Product Portfolios and Specifications
13.3.3 Taiclone Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Taiclone Main Business Overview
13.3.5 Taiclone Latest Developments
13.4 Clearsynth
13.4.1 Clearsynth Company Information
13.4.2 Clearsynth Rimegepant API Product Portfolios and Specifications
13.4.3 Clearsynth Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Clearsynth Main Business Overview
13.4.5 Clearsynth Latest Developments
13.5 TargetMol Chemicals
13.5.1 TargetMol Chemicals Company Information
13.5.2 TargetMol Chemicals Rimegepant API Product Portfolios and Specifications
13.5.3 TargetMol Chemicals Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TargetMol Chemicals Main Business Overview
13.5.5 TargetMol Chemicals Latest Developments
13.6 AbMole BioScience
13.6.1 AbMole BioScience Company Information
13.6.2 AbMole BioScience Rimegepant API Product Portfolios and Specifications
13.6.3 AbMole BioScience Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AbMole BioScience Main Business Overview
13.6.5 AbMole BioScience Latest Developments
13.7 Toronto Research Chemicals
13.7.1 Toronto Research Chemicals Company Information
13.7.2 Toronto Research Chemicals Rimegepant API Product Portfolios and Specifications
13.7.3 Toronto Research Chemicals Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Toronto Research Chemicals Main Business Overview
13.7.5 Toronto Research Chemicals Latest Developments
13.8 Metrochem
13.8.1 Metrochem Company Information
13.8.2 Metrochem Rimegepant API Product Portfolios and Specifications
13.8.3 Metrochem Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Metrochem Main Business Overview
13.8.5 Metrochem Latest Developments
13.9 Aurobindo
13.9.1 Aurobindo Company Information
13.9.2 Aurobindo Rimegepant API Product Portfolios and Specifications
13.9.3 Aurobindo Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aurobindo Main Business Overview
13.9.5 Aurobindo Latest Developments
13.10 Hetero Drugs
13.10.1 Hetero Drugs Company Information
13.10.2 Hetero Drugs Rimegepant API Product Portfolios and Specifications
13.10.3 Hetero Drugs Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hetero Drugs Main Business Overview
13.10.5 Hetero Drugs Latest Developments
13.11 Moehs Iberica
13.11.1 Moehs Iberica Company Information
13.11.2 Moehs Iberica Rimegepant API Product Portfolios and Specifications
13.11.3 Moehs Iberica Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Moehs Iberica Main Business Overview
13.11.5 Moehs Iberica Latest Developments
13.12 Changzhou Pharmaceutical Factory
13.12.1 Changzhou Pharmaceutical Factory Company Information
13.12.2 Changzhou Pharmaceutical Factory Rimegepant API Product Portfolios and Specifications
13.12.3 Changzhou Pharmaceutical Factory Rimegepant API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Changzhou Pharmaceutical Factory Main Business Overview
13.12.5 Changzhou Pharmaceutical Factory Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rimegepant API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rimegepant API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global Rimegepant API Sales by Type (2018-2023) & (Tons)
Table 6. Global Rimegepant API Sales Market Share by Type (2018-2023)
Table 7. Global Rimegepant API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rimegepant API Revenue Market Share by Type (2018-2023)
Table 9. Global Rimegepant API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Rimegepant API Sales by Application (2018-2023) & (Tons)
Table 11. Global Rimegepant API Sales Market Share by Application (2018-2023)
Table 12. Global Rimegepant API Revenue by Application (2018-2023)
Table 13. Global Rimegepant API Revenue Market Share by Application (2018-2023)
Table 14. Global Rimegepant API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Rimegepant API Sales by Company (2018-2023) & (Tons)
Table 16. Global Rimegepant API Sales Market Share by Company (2018-2023)
Table 17. Global Rimegepant API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rimegepant API Revenue Market Share by Company (2018-2023)
Table 19. Global Rimegepant API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Rimegepant API Producing Area Distribution and Sales Area
Table 21. Players Rimegepant API Products Offered
Table 22. Rimegepant API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rimegepant API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Rimegepant API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rimegepant API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rimegepant API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rimegepant API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Rimegepant API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rimegepant API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rimegepant API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rimegepant API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Rimegepant API Sales Market Share by Country (2018-2023)
Table 35. Americas Rimegepant API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rimegepant API Revenue Market Share by Country (2018-2023)
Table 37. Americas Rimegepant API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Rimegepant API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Rimegepant API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Rimegepant API Sales Market Share by Region (2018-2023)
Table 41. APAC Rimegepant API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rimegepant API Revenue Market Share by Region (2018-2023)
Table 43. APAC Rimegepant API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Rimegepant API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Rimegepant API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Rimegepant API Sales Market Share by Country (2018-2023)
Table 47. Europe Rimegepant API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rimegepant API Revenue Market Share by Country (2018-2023)
Table 49. Europe Rimegepant API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Rimegepant API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Rimegepant API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Rimegepant API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rimegepant API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rimegepant API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rimegepant API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Rimegepant API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Rimegepant API
Table 58. Key Market Challenges & Risks of Rimegepant API
Table 59. Key Industry Trends of Rimegepant API
Table 60. Rimegepant API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rimegepant API Distributors List
Table 63. Rimegepant API Customer List
Table 64. Global Rimegepant API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Rimegepant API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rimegepant API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Rimegepant API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rimegepant API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Rimegepant API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rimegepant API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Rimegepant API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rimegepant API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Rimegepant API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rimegepant API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Rimegepant API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rimegepant API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Rimegepant API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Cayman Chemical Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 79. Cayman Chemical Rimegepant API Product Portfolios and Specifications
Table 80. Cayman Chemical Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Cayman Chemical Main Business
Table 82. Cayman Chemical Latest Developments
Table 83. MedKoo Biosciences Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 84. MedKoo Biosciences Rimegepant API Product Portfolios and Specifications
Table 85. MedKoo Biosciences Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. MedKoo Biosciences Main Business
Table 87. MedKoo Biosciences Latest Developments
Table 88. Taiclone Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 89. Taiclone Rimegepant API Product Portfolios and Specifications
Table 90. Taiclone Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Taiclone Main Business
Table 92. Taiclone Latest Developments
Table 93. Clearsynth Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 94. Clearsynth Rimegepant API Product Portfolios and Specifications
Table 95. Clearsynth Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Clearsynth Main Business
Table 97. Clearsynth Latest Developments
Table 98. TargetMol Chemicals Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 99. TargetMol Chemicals Rimegepant API Product Portfolios and Specifications
Table 100. TargetMol Chemicals Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. TargetMol Chemicals Main Business
Table 102. TargetMol Chemicals Latest Developments
Table 103. AbMole BioScience Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 104. AbMole BioScience Rimegepant API Product Portfolios and Specifications
Table 105. AbMole BioScience Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. AbMole BioScience Main Business
Table 107. AbMole BioScience Latest Developments
Table 108. Toronto Research Chemicals Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 109. Toronto Research Chemicals Rimegepant API Product Portfolios and Specifications
Table 110. Toronto Research Chemicals Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Toronto Research Chemicals Main Business
Table 112. Toronto Research Chemicals Latest Developments
Table 113. Metrochem Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 114. Metrochem Rimegepant API Product Portfolios and Specifications
Table 115. Metrochem Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Metrochem Main Business
Table 117. Metrochem Latest Developments
Table 118. Aurobindo Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 119. Aurobindo Rimegepant API Product Portfolios and Specifications
Table 120. Aurobindo Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Aurobindo Main Business
Table 122. Aurobindo Latest Developments
Table 123. Hetero Drugs Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 124. Hetero Drugs Rimegepant API Product Portfolios and Specifications
Table 125. Hetero Drugs Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Hetero Drugs Main Business
Table 127. Hetero Drugs Latest Developments
Table 128. Moehs Iberica Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 129. Moehs Iberica Rimegepant API Product Portfolios and Specifications
Table 130. Moehs Iberica Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Moehs Iberica Main Business
Table 132. Moehs Iberica Latest Developments
Table 133. Changzhou Pharmaceutical Factory Basic Information, Rimegepant API Manufacturing Base, Sales Area and Its Competitors
Table 134. Changzhou Pharmaceutical Factory Rimegepant API Product Portfolios and Specifications
Table 135. Changzhou Pharmaceutical Factory Rimegepant API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Changzhou Pharmaceutical Factory Main Business
Table 137. Changzhou Pharmaceutical Factory Latest Developments
List of Figures
Figure 1. Picture of Rimegepant API
Figure 2. Rimegepant API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rimegepant API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Rimegepant API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rimegepant API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ≥ 98 %
Figure 10. Product Picture of Purity ≥ 99 %
Figure 11. Global Rimegepant API Sales Market Share by Type in 2022
Figure 12. Global Rimegepant API Revenue Market Share by Type (2018-2023)
Figure 13. Rimegepant API Consumed in Research Institute
Figure 14. Global Rimegepant API Market: Research Institute (2018-2023) & (Tons)
Figure 15. Rimegepant API Consumed in Pharmaceutical
Figure 16. Global Rimegepant API Market: Pharmaceutical (2018-2023) & (Tons)
Figure 17. Rimegepant API Consumed in Others
Figure 18. Global Rimegepant API Market: Others (2018-2023) & (Tons)
Figure 19. Global Rimegepant API Sales Market Share by Application (2022)
Figure 20. Global Rimegepant API Revenue Market Share by Application in 2022
Figure 21. Rimegepant API Sales Market by Company in 2022 (Tons)
Figure 22. Global Rimegepant API Sales Market Share by Company in 2022
Figure 23. Rimegepant API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Rimegepant API Revenue Market Share by Company in 2022
Figure 25. Global Rimegepant API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Rimegepant API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Rimegepant API Sales 2018-2023 (Tons)
Figure 28. Americas Rimegepant API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Rimegepant API Sales 2018-2023 (Tons)
Figure 30. APAC Rimegepant API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Rimegepant API Sales 2018-2023 (Tons)
Figure 32. Europe Rimegepant API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Rimegepant API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Rimegepant API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Rimegepant API Sales Market Share by Country in 2022
Figure 36. Americas Rimegepant API Revenue Market Share by Country in 2022
Figure 37. Americas Rimegepant API Sales Market Share by Type (2018-2023)
Figure 38. Americas Rimegepant API Sales Market Share by Application (2018-2023)
Figure 39. United States Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Rimegepant API Sales Market Share by Region in 2022
Figure 44. APAC Rimegepant API Revenue Market Share by Regions in 2022
Figure 45. APAC Rimegepant API Sales Market Share by Type (2018-2023)
Figure 46. APAC Rimegepant API Sales Market Share by Application (2018-2023)
Figure 47. China Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Rimegepant API Sales Market Share by Country in 2022
Figure 55. Europe Rimegepant API Revenue Market Share by Country in 2022
Figure 56. Europe Rimegepant API Sales Market Share by Type (2018-2023)
Figure 57. Europe Rimegepant API Sales Market Share by Application (2018-2023)
Figure 58. Germany Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Rimegepant API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Rimegepant API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Rimegepant API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Rimegepant API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Rimegepant API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Rimegepant API in 2022
Figure 73. Manufacturing Process Analysis of Rimegepant API
Figure 74. Industry Chain Structure of Rimegepant API
Figure 75. Channels of Distribution
Figure 76. Global Rimegepant API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Rimegepant API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Rimegepant API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Rimegepant API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Rimegepant API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Rimegepant API Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のリメゲパントAPI市場予測 2023年-2029年(Global Rimegepant API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のリメゲパントAPI市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp